Investigational Site Number : 250004

Paris 75674

1 studies enrolling now · 6 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Cancer, Glycogen Storage Disease Type II, Pompe Disease, Prostate Cancer, Rheumatoid Arthritis, Squamous Cell Lung Cancer, Venous Thromboembolism

Studies at this site

• Pompe Disease Registry Protocol — Recruiting now
• Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate — Stopped early
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed